Definium Therapeutics, Inc.

DFTX Healthcare Biotechnology

In the quarter to June 2026, EPS fell 188.0%, free cash flow fell 78.3% and total debt fell 11.5%, each against the same quarter a year earlier.

32.10 2.16 −6.30%
Market cap
$4.6B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
411.59 273.74 99.70 142.14 133.54 80.09 0.01 0.11 1.35 0.10
Receivables
— — — — — — — 0.01 0.01 0.00
Other current assets
— — — — — — — 0.03 0.06 0.00
Total current assets
419.32 281.62 103.87 146.06 137.22 81.52 2.26 0.15 1.42 0.10
Property, Plant, Equpment (Net)
— — — — — — — 0.05 0.06 —
Long-Term Investments
— — — — — — — 0.10 0.06 —
Goodwill and Intangible Assets (Total)
19.92 19.92 20.45 23.61 26.79 3.68 0.00 — — —
Long-term assets (Other)
0.86 0.61 0.22 0.33 — — — 2.30 1.69 0.05
Total non-current assets
20.78 20.53 20.67 23.94 26.79 — — — — —
Total Assets
440.10 302.15 124.54 169.99 164.00 81.52 — 2.60 — 0.15
Accounts Payable
5.35 2.01 4.14 2.11 4.18 2.02 — — — —
Accrued Expenses
20.45 12.83 11.63 5.88 6.23 0.99 — — — —
Current Part of Debt
— — — — — — — — 0.01 —
Current Part of Capital Lease
— — — — — — 0.00 — — —
Current Part of Taxes to Pay
— — — — — — 0.00 — — —
Other current liabilities
40.91 24.01 16.48 9.90 8.20 2.37 0.15 0.01 0.05 0.06
Total current liabilities
66.70 38.85 32.25 17.89 10.41 3.01 0.15 0.01 0.06 0.06
Long Term Debt (Total)
40.58 21.85 14.13 — — — — — — —
Non-current Revenue (Deferred)
— — — — — — 0.00 — — —
Minority Interests
— — — — — — 0.00 — — —
Non-current Liabilities (Other)
0.50 — 0.03 1.18 1.93 2.64 — — — —
Total non-current liabilities
41.08 21.85 14.16 1.18 1.93 2.64 — — — —
Total liabilities
107.77 60.70 46.41 19.08 12.34 5.65 — 0.01 0.06 0.06
Additional Paid In Capital
913.91 639.51 367.99 344.76 288.29 120.22 0.00 — — —
Preferred Stock (Total)
— — — — — — 0.00 — — —
Common Stock (Net)
— — — — — — 0.00 3.91 4.13 0.42
Retained Earnings
(582.67) (398.88) (290.20) (194.47) (137.67) (44.64) (2.81) (1.90) (1.45) (0.37)
Treasury Stock
— — — — — — 0.00 — — —
Shareholders Equity (Other)
— — — — — — 0.00 — — —
Common Equity (Total)
332.33 241.45 78.13 150.92 151.66 75.87 2.11 2.59 3.16 0.09
Shareholders Equity (Total)
332.33 241.45 78.13 150.92 151.66 75.87 — 2.59 3.16 0.09
Shareholders Equity and Liabilities (Total)
440.10 302.15 124.54 169.99 164.00 81.52 — — — —
Shares (Common)
98.78 75.10 41.10 37.98 28.13 20.46 — — — —
Shareholders Equity (Tangible)
312.41 221.53 57.69 127.31 124.88 75.87 — — — —
Net Debt
(371.01) (251.89) (85.57) (142.14) (133.54) (80.09) (0.01) (0.11) (1.34) (0.10)
Total Debt
40.58 21.85 14.13 0.05 — — — — 0.01 —

Fold the line items

In millions of $ except per-share values · columns are period end dates